Latest Biotech News

Eli Lilly expanded its collaboration with China’s Innovent Biologics under a deal worth up to $8.8 billion, including $350 million in upfront payments to jointly develop oncology and immunology...

Aerska Therapeutics, a startup developing 'brain shuttle' technology to deliver larger molecules across the blood‑brain barrier, raised $39 million in a follow‑on financing, the company told STAT....

Researchers reported in Nature Communications that combining bacteriophage therapy with traditional antibiotics cleared refractory Klebsiella pneumoniae peritonitis in a preclinical model of...

A sector briefing from Catalent and industry analysts highlighted the acute complexity of cell and gene therapy (CGT) supply chains—ranging from collection and chain‑of‑identity to manufacturing,...

Las Vegas police arrested an Israeli citizen following a raid on an alleged illicit biolab where multiple people reportedly became 'deathly ill.' Authorities seized more than 1,000 samples,...

OpenEvidence reached a reported $12 billion valuation as investors rewarded rapid clinician adoption of its AI medical search tool, which the company says is used regularly by more than 430,000...

Eli Lilly agreed to expand its collaboration with Innovent Biologics via a new deal that includes a $350 million upfront payment to develop oncology and immunology programs. The agreement—reported...

Telehealth firm Hims & Hers said it will stop offering a compounded version of Novo Nordisk’s Wegovy following legal pressure from regulators and industry challengers. The company faced federal...

Roivant Sciences’ subsidiary Priovant Therapeutics reported that brepocitinib, a dual JAK1/TYK2 inhibitor licensed from Pfizer, met the goals of a proof‑of‑concept study in cutaneous sarcoidosis....

Sanofi presented data from a failed Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS), explaining the company’s decision to withdraw from that...

Las Vegas police arrested an Israeli national and seized more than 1,000 samples and laboratory equipment from a residential property after several people reported becoming “deathly ill,”...

Researchers published a Nature Communications study showing a combination of bacteriophages and antibiotics effectively treated refractory peritoneal dialysis‑related peritonitis caused by...

Researchers at the Centre for Cellular and Molecular Biology (CCMB) reported that metabolic pathways underlie fungal invasion and influence responses to antifungal therapy. The team identified...

A research team reported that simultaneous modulation of STING, TGF‑β, and PD‑L1 pathways markedly enhanced antitumor responses via the CXCL16–CXCR6 signaling axis. The triple‑targeting approach...

A Nature Communications study led by Chey, Kashgari, and McLeod identified the inflammasome‑associated protein ASC as a central regulator connecting innate immune signaling to mitochondrial...

Researchers published a Nature Communications report introducing a 3D gut‑brain‑vascular platform that models communication among the gut, brain, and vasculature. The system reproduces key...

Roivant subsidiary Priovant reported that brepocitinib, a dual JAK1/TYK2 inhibitor licensed from Pfizer, met the primary goals of a proof-of-concept study in cutaneous sarcoidosis. The trial...

Sanofi disclosed data from a failed Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS), prompting the company to retreat from that indication. The...

Researchers published a Nature Communications study showing a bacteriophage–antibiotic combination cured refractory peritoneal dialysis–related peritonitis caused by multidrug-resistant Klebsiella...

A Nature Communications paper by Chey, Kashgari, McLeod and colleagues identified the inflammasome-associated protein ASC as a central regulator connecting innate immune signaling to mitochondrial...